On this page you will find our recommendations sorted by BNF chapter.

Appraisal Reports are available to stakeholders on request.

Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net

Title Documents Decision Date

New

07/06/2022
Budesonide orodispersible for maintenance treatment of eosinophilic oesophagitis Recommendation Recommended as an option 07/06/2022
Infliximab biosimilars See Musculoskeletal and joint diseases recommendations Recommended as an option 02/06/2015
Infliximab Subcutaneous (Remsima®) Musculoskeletal and joint diseases recommendations Recommended as an option during Covid-19 Pandemic. 08/06/2021
Leukapheresis with Adacolumn™ for Inflammatory Bowel Disease (NETAG) Recommendation Not recommended 18/01/2011
Transanal Irrigation Systems (TAIs) for neurogenic bowel dysfunction, chronic constipation, and chronic faecal incontinence Recommendation Recommended for restricted use 08/06/2021